Stay updated on Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    - The page revision was updated from v3.5.3 to v3.5.4, reflecting a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-05-15T05:53:32.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    21 days ago
    Change Detected
    Summary
    This update reflects a change in the ClinicalTrials.gov page revision/version number from v3.5.2 to v3.5.3, indicating a site release rather than a modification to the study record itself.
    Difference
    0.1%
    Check dated 2026-04-24T05:48:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    - Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:12:52.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Added site revision tag v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T20:34:44.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T18:03:56.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The site version was updated to Revision: v3.4.2 and an older government funding status notice was removed, with no changes to the study details or content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T05:34:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for High Risk Oral Neoplasia Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for High Risk Oral Neoplasia Clinical Trial page.